Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice

被引:123
|
作者
Tsukamoto, O
Minamino, T
Okada, K
Shintani, Y
Takashima, S
Kato, H
Liao, YL
Okazaki, H
Asai, M
Hirata, A
Fujita, M
Asano, Y
Yamazaki, S
Asanuma, H
Hori, M
Kitakaze, M [1 ]
机构
[1] Natl Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka 5658565, Japan
[2] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan
关键词
ubiquitin-proteasome; apoptosis heart failure; protein degradation;
D O I
10.1016/j.bbrc.2005.12.120
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitin-proteasome system contributes to regulation of apoptosis degrading apoptosis-regulatory proteins. Marked accumulation of ubiquitinated proteins in cardiomyocytes of human failing hearts suggested impaired Ubiquitin-proteasome system in heart failure. Since cardiomyocyte apoptosis contributes to the progression of cardiac dysfunction in pressure-overloaded hearts, we investigated the role of ubiquitin-proteasome system in such conditions. We found that proteasome activities already depressed before the onset of cardiac dysfunction in pressure-overloaded hearts of mice. Cardiomyocyte apoptosis was observed along with depression of proteasome activities and elevation of proapoptotic/antiapoptotic protein ratio in failing hearts. in Cultured cardiomyocytes, pharmacological inhibition of proteasome accumulated proapoptotic proteins such as p53 and Bax. Gene silencing of these proapoptotic proteins by RNA interference prevented the accumulation of respective proteins and attenuated cardiomyocyte apoptosis induced by proteasome inhibition. We conclude that depression of proteasome activities contributes to cardiac dysfunction resulting from cardiomyocyte apoptosis through accumulation of proapoptotic proteins by impaired degradation. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 50 条
  • [41] Targeting a cardiac abundant and fibroblasts-specific piRNA (CFRPi) to attenuate and reverse cardiac fibrosis in pressure-overloaded heart failure
    Chen, Bo
    Shi, Bozhong
    Zhou, Zijie
    Cui, Yue
    Zeng, Guowei
    Cheng, Lingyan
    Zhang, Xiaoyang
    Luo, Kai
    Li, Cong
    Zhu, Zhongqun
    Zhang, Zhifang
    Zheng, Jinghao
    He, Xiaomin
    TRANSLATIONAL RESEARCH, 2024, 267 : 10 - 24
  • [42] Mitochondria Dysfunction Precedes Cardiomyocyte Apoptosis in the Pressure-Overloaded Neonatal Left Ventricle
    Griffiths, Eric R.
    Friehs, Ingeborg
    Scherr, Elisabeth
    Poutias, Dimitrios N.
    McGowan, Francis X., Jr.
    del Nido, Pedro J.
    CIRCULATION, 2008, 118 (18) : S750 - S750
  • [43] Mechanisms of Chinese Medicine Xinmailong's protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes
    Qi, Jianyong
    Yu, Juan
    Tan, Yafang
    Chen, Renshan
    Xu, Wen
    Chen, Yanfen
    Lu, Jun
    Liu, Qin
    Wu, Jiashin
    Gu, Weiwang
    Zhang, Minzhou
    SCIENTIFIC REPORTS, 2017, 7
  • [44] Atorvastatin, Valsartan, and N-Acetylcysteine Prevent Cardiac Hypertrophy and Overexpression of Myocardin in Pressure-Overloaded Rat Heart
    Chiu, Chiung-Zuan
    Wang, Bao-Wei
    Shyu, Kou-Gi
    ACTA CARDIOLOGICA SINICA, 2012, 28 (04) : 286 - 296
  • [45] Adenylyl Cyclase 6 Deletion Reduces Left Ventricular Hypertrophy, Dilation, Dysfunction, and Fibrosis in Pressure-Overloaded Female Mice
    Tang, Tong
    Lai, N. Chin
    Hammond, H. Kirk
    Roth, David M.
    Yang, Yuan
    Guo, Tracy
    Gao, Mei Hua
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (14) : 1476 - 1486
  • [46] Early changes in protein synthesis in epicardial coronary artery of pressure-overloaded heart
    Gerova, M
    Pechanova, O
    Stoev, V
    Kittova, M
    Bernatova, I
    Barta, E
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 270 (02): : H685 - H691
  • [47] Synthetic Prostacyclin Agonist Attenuates Pressure-Overloaded Cardiac Fibrosis by Inhibiting FMT
    Masada, Kenta
    Miyagawa, Shigeru
    Sakai, Yoshiki
    Harada, Akima
    Kanaya, Tomomitsu
    Sawa, Yoshiki
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 19 : 210 - 219
  • [48] Evidence for contractile dysfunction and heart failure in pressure-overloaded wild-type mice - does the PGC-1alpha story hold true?
    Faerber, G.
    Barreto-Pereira, H. F.
    Gilsbach, R.
    Schoepe, M.
    Schwarzer, M.
    Hein, L.
    Doenst, T.
    EUROPEAN HEART JOURNAL, 2009, 30 : 286 - 286
  • [49] EXPRESSION OF CELLULAR ONCOGENES IN THE MYOCARDIUM DURING THE DEVELOPMENTAL STAGE AND PRESSURE-OVERLOADED HYPERTROPHY OF THE RAT-HEART
    KOMURO, I
    KURABAYASHI, M
    TAKAKU, F
    YAZAKI, Y
    CIRCULATION RESEARCH, 1988, 62 (06) : 1075 - 1079
  • [50] Mechanisms of Chinese Medicine Xinmailong’s protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes
    Jianyong Qi
    Juan Yu
    Yafang Tan
    Renshan Chen
    Wen Xu
    Yanfen Chen
    Jun Lu
    Qin Liu
    Jiashin Wu
    Weiwang Gu
    Minzhou Zhang
    Scientific Reports, 7